TB Alternative Assets’s Idexx Laboratories IDXX Stock Holding History

TB Alternative Assets’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-615	Closed	-$416K	–	50
2025 Q4	$416K	Hold	615	–	–	0.07%	43
2025 Q3	$393K	Buy	+615	New	+$373K	0.06%	43

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TB Alternative Assets's IDXX Position: Q1 2026 in Review

TB Alternative Assets sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 615 shares — an estimated $416K sold.

TB Alternative Assets first reported a position in IDXX in Q3 2025 and held it in 2 quarters. The position peaked at $416K in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

TB Alternative Assets reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
TB Alternative Assets sold 615 Idexx Laboratories shares in Q1 2026, an estimated $416K.
TB Alternative Assets first reported a position in Idexx Laboratories in Q3 2025 and held it in 2 quarters.
TB Alternative Assets's Idexx Laboratories position peaked at $416K in Q4 2025.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on TB Alternative Assets's 13F filing for Q1 2026, filed 16 Apr 2026.